$VTRS
Viatris Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$17.71
▲+0.62%+$0.110
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateViatris Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is VTRS up today? It is at $17.71 (+0.62%), and our scanner flagged it 82 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VTRS spikes, and full due diligence on VTRS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VTRS 82 times in the last 30 days. Create a free account to track $VTRS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
VTRS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on VTRS today, peaking at 10.3x its normal volume. A recent catalyst in the news: “Viatris (VTRS) is a Top-Ranked Momentum Stock: Should You Buy?.” Early read: bullish.
Likely catalystViatris Inc: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Oct 2, 2026 · 2 days agoA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Enrietti Andrew Officer | Sold (automatic/other) | -11K | sold 4.6% | 234K | $184K at $16.23 | Aug 15, 26 |
Enrietti Andrew Officer | Other | 26K | added 12% | 245K | n/a | Aug 15, 26 |
Campbell Paul Officer | Sold (automatic/other) | -50K | sold 14% | 316K | $810K at $16.17 | Jun 25, 26 |
Le Goff Corinne Officer | Sold (automatic/other) | -19K | sold 15% | 105K | $264K at $13.86 | Apr 15, 26 |
Le Goff Corinne Officer | Other | 43K | added 54% | 123K | n/a | Apr 15, 26 |
Campbell Paul Officer | Sold (automatic/other) | -21K | sold 5.5% | 366K | $284K at $13.28 | Mar 23, 26 |
Cornwell W Don Director | Other | 25K | added 28% | 112K | n/a | Mar 6, 26 |
Finney Elisha W Director | Other | 25K | added 66% | 63K | n/a | Mar 6, 26 |
Vivaldi Coelho Rogerio Director | Other | 25K | added 100% | 47K | n/a | Mar 6, 26 |
Parrish Mark W Director | Other | 25K | added 18% | 165K | n/a | Mar 6, 26 |
Kilts James M Director | Other | 25K | added 18% | 161K | n/a | Mar 6, 26 |
Campbell Paul Officer | Sold (automatic/other) | -13K | sold 3.2% | 387K | $180K at $14.16 | Mar 6, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
VTRS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 5 unusual-volume and momentum alerts on VTRS today, peaking at 10.3x its normal volume. A recent catalyst in the news: “Viatris (VTRS) is a Top-Ranked Momentum Stock: Should You Buy?.” Early read: bullish.
VTRS last traded at $17.71, up 0.62% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Viatris Inc. Common Stock (VTRS) is next expected to report earnings on Thursday, November 5, 2026, about 31 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. VTRS currently has a dividend yield of about 2.73% ($0.48 per share per year). Dividend figures can change; this is not investment advice.
The VTRS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VTRS 82 times in the last 30 days.
VTRS (Viatris Inc. Common Stock) trades on XNAS, with a market cap of about $20.22B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VTRS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VTRS discussion
Sign in to ask a question or join the discussion.